Transcode Therapeutics reported total assets of $151.01M and total liabilities of $178.71M for the quarter ended Jun 2026. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.04M | 0.06M | 0.09M | 0.11M | 0.14M | 0.17M | 0.20M | 0.23M | 0.26M | 0.30M | 0.33M | 0.34M | 0.31M | 0.32M | 0.34M | 0.34M | 0.39M | 0.41M | 0.44M | ||||||
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 22.50M | 20.83M | 16.90M | 13.44M | 8.80M | 4.97M | 1.62M | 3.60M | 7.50M | 2.77M | 4.91M | 3.40M | 1.90M | 5.81M | 11.60M | 7.40M | 2.84M | 17.81M | 12.84M | 8.40M | |||||
| Receivables - OtherOther Receivables | 0.49M | 0.36M | 0.01M | 0.32M | 0.18M | 0.20M | 0.95M | 638.00 | 638.00 | ||||||||||||||||
| Prepaid Assets | 2.70M | 1.91M | 1.78M | 0.48M | 2.29M | 2.05M | 2.72M | 1.32M | 1.92M | 1.69M | 1.80M | 1.03M | 1.72M | 1.28M | 1.15M | 0.69M | 1.72M | 0.92M | 1.62M | 2.26M | |||||
| Current Assets | 25.20M | 22.73M | 18.63M | 13.92M | 11.57M | 7.38M | 4.35M | 4.89M | 9.37M | 4.46M | 6.71M | 4.39M | 3.61M | 7.09M | 13.04M | 8.24M | 4.75M | 21.98M | 16.75M | 10.64M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.16M | 0.21M | 0.22M | 0.23M | 0.21M | 0.21M | 0.19M | 0.18M | 0.15M | 0.12M | 0.09M | 0.06M | 0.06M | 0.05M | 0.04M | 0.02M | 0.02M | 0.37M | 0.35M | 0.32M | |||||
| Goodwill | 25.74M | 25.74M | 25.74M | ||||||||||||||||||||||
| Intangibles | 114.30M | 114.30M | 114.30M | ||||||||||||||||||||||
| Goodwill & Intangibles | 140.04M | 140.04M | 140.04M | ||||||||||||||||||||||
| Other Non-Current Assets | 0.24M | 0.14M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.46M | 0.03M | |||||||||||||
| Non-Current Assets | 0.16M | 0.21M | 0.22M | 0.23M | 0.45M | 0.21M | 1.24M | 0.99M | 0.85M | 0.71M | 0.58M | 0.44M | 0.32M | 0.20M | 0.15M | 0.02M | 0.48M | 140.41M | 140.42M | 140.37M | |||||
| Assets | 25.36M | 22.94M | 18.85M | 14.16M | 12.02M | 7.59M | 5.59M | 5.88M | 10.23M | 5.17M | 7.29M | 4.82M | 3.94M | 7.29M | 13.19M | 8.27M | 5.23M | 162.40M | 157.16M | 151.01M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 1.98M | 2.50M | 1.83M | 1.70M | 3.75M | 4.35M | 5.06M | 3.04M | 5.14M | 3.05M | 2.37M | 3.28M | 2.13M | 2.71M | 2.51M | 1.56M | 2.97M | 3.49M | 5.29M | 4.68M | |||||
| Notes Payables | 0.65M | ||||||||||||||||||||||||
| Payables | 1.98M | 2.50M | 1.83M | 1.70M | 3.75M | 4.35M | 5.06M | 3.04M | 5.14M | 3.05M | 2.37M | 3.28M | 2.13M | 2.71M | 2.51M | 1.56M | 2.97M | 3.49M | 5.29M | 5.33M | |||||
| Current Deferred Revenue | 0.22M | 0.03M | 0.02M | 0.02M | 0.02M | 0.08M | 0.05M | 0.03M | 0.03M | 0.03M | 0.09M | 0.06M | |||||||||||||
| Total Current Liabilities | 2.20M | 2.53M | 1.85M | 1.73M | 3.77M | 4.35M | 5.45M | 3.52M | 5.60M | 3.49M | 2.71M | 3.50M | 2.28M | 2.77M | 2.51M | 1.56M | 2.97M | 3.49M | 5.38M | 5.40M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Convertible Debt | |||||||||||||||||||||||||
| Preferred Stock Liabilities | 141.54M | 143.27M | 166.05M | ||||||||||||||||||||||
| Operating Leases | 0.38M | 0.27M | 0.19M | 0.04M | |||||||||||||||||||||
| Non-Current Deferred Tax Liability | 0.23M | 0.46M | 0.46M | ||||||||||||||||||||||
| Other Non-Current Liabilities | 0.52M | 0.39M | 0.55M | 0.83M | 6.36M | 6.25M | 6.46M | ||||||||||||||||||
| Total Non-Current Liabilities | 0.04M | 6.54M | 0.39M | 0.55M | 0.83M | 7.02M | 7.27M | 7.25M | |||||||||||||||||
| Total Liabilities | 2.20M | 2.53M | 1.85M | 1.73M | 3.77M | 4.35M | 5.83M | 3.79M | 5.79M | 3.53M | 2.71M | 3.50M | 2.28M | 9.31M | 2.90M | 2.12M | 3.80M | 152.06M | 155.91M | 178.71M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Total Debt | 0.65M | ||||||||||||||||||||||||
| Common Equity | 23.16M | 20.40M | 17.00M | 12.43M | 8.24M | 3.24M | -0.24M | 2.09M | 4.44M | 1.64M | 4.58M | 1.32M | 1.65M | -2.02M | 10.29M | 6.15M | 1.43M | 10.34M | 1.25M | -27.69M | |||||
| Liabilities and Shareholders Equity | 25.36M | 22.94M | 18.85M | 14.16M | 12.02M | 7.59M | 5.59M | 5.88M | 10.23M | 5.17M | 7.29M | 4.82M | 3.94M | 7.29M | 13.19M | 8.27M | 5.23M | 162.40M | 157.16M | 151.01M | |||||
| Retained Earnings | -7.51M | -10.31M | -13.80M | -18.45M | -22.74M | -27.87M | -32.70M | -37.03M | -42.33M | -46.42M | -49.74M | -54.93M | -57.30M | -63.20M | -75.30M | -79.60M | -84.42M | -97.86M | -115.65M | -122.40M | |||||
| Preferred Shares | 121.00 | 121.00 |
Pull Transcode Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RNAZ&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RNAZ", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RNAZ&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();